178 related articles for article (PubMed ID: 7786309)
1. Blockade of human neutrophil activation by 2-[2-propyl-3-[3-[2-ethyl-4-(4-fluorophenyl)-5- hydroxyphenoxy]propoxy]phenoxy]benzoic acid (LY293111), a novel leukotriene B4 receptor antagonist.
Marder P; Sawyer JS; Froelich LL; Mann LL; Spaethe SM
Biochem Pharmacol; 1995 May; 49(11):1683-90. PubMed ID: 7786309
[TBL] [Abstract][Full Text] [Related]
2. Pharmacologic actions of the second-generation leukotriene B4 receptor antagonist LY293111: in vitro studies.
Jackson WT; Froelich LL; Boyd RJ; Schrementi JP; Saussy DL; Schultz RM; Sawyer JS; Sofia MJ; Herron DK; Goodson T; Snyder DW; Pechous PA; Spaethe SM; Roman CR; Fleisch JH
J Pharmacol Exp Ther; 1999 Jan; 288(1):286-94. PubMed ID: 9862783
[TBL] [Abstract][Full Text] [Related]
3. Synthetic and structure/activity studies on acid-substituted 2-arylphenols: discovery of 2-[2-propyl-3-[3-[2-ethyl-4-(4-fluorophenyl)-5- hydroxyphenoxy]-propoxy]phenoxy]benzoic acid, a high-affinity leukotriene B4 receptor antagonist.
Sawyer JS; Bach NJ; Baker SR; Baldwin RF; Borromeo PS; Cockerham SL; Fleisch JH; Floreancig P; Froelich LL; Jackson WT
J Med Chem; 1995 Oct; 38(22):4411-32. PubMed ID: 7473568
[TBL] [Abstract][Full Text] [Related]
4. Antiinflammatory effects of second-generation leukotriene B4 receptor antagonist, SC-53228: impact upon leukotriene B4- and 12(R)-HETE-mediated events.
Fretland DJ; Anglin CP; Bremer M; Isakson P; Widomski DL; Paulson SK; Docter SH; Djuric SW; Penning TD; Yu S
Inflammation; 1995 Apr; 19(2):193-205. PubMed ID: 7601505
[TBL] [Abstract][Full Text] [Related]
5. The regulation of CD11b integrin levels on human blood leukocytes and leukotriene B4-stimulated skin by a specific leukotriene B4 receptor antagonist (LY293111).
van Pelt JP; de Jong EM; van Erp PE; Mitchell MI; Marder P; Spaethe SM; van Hooijdonk CA; Kuijpers AL; van de Kerkhof PC
Biochem Pharmacol; 1997 Apr; 53(7):1005-12. PubMed ID: 9174114
[TBL] [Abstract][Full Text] [Related]
6. Leukotriene B4-induced granulocyte trafficking in guinea pig dermis. Effect of second-generation leukotriene B4 receptor antagonists, SC-50605 and SC-51146.
Fretland DJ; Widomski DL; Anglin CP; Penning TD; Yu S; Djuric SW
Inflammation; 1993 Jun; 17(3):353-60. PubMed ID: 8392493
[TBL] [Abstract][Full Text] [Related]
7. Effects of two leukotriene B4 (LTB4) receptor antagonists (LY255283 and SC-41930) on LTB4-induced human neutrophil adhesion and superoxide production.
Schultz RM; Marder P; Spaethe SM; Herron DK; Sofia MJ
Prostaglandins Leukot Essent Fatty Acids; 1991 Aug; 43(4):267-71. PubMed ID: 1658812
[TBL] [Abstract][Full Text] [Related]
8. Pharmacologic actions of the second generation leukotriene B4 receptor antagonist LY29311: in vivo pulmonary studies.
Silbaugh SA; Stengel PW; Cockerham SL; Froelich LL; Bendele AM; Spaethe SM; Sofia MJ; Sawyer JS; Jackson WT
Naunyn Schmiedebergs Arch Pharmacol; 2000 Apr; 361(4):397-404. PubMed ID: 10763854
[TBL] [Abstract][Full Text] [Related]
9. SC-41930: an inhibitor of leukotriene B4-stimulated human neutrophil functions.
Tsai BS; Villani-Price D; Keith RH; Zemaitis JM; Bauer RF; Leonard R; Djuric SW; Shone RL
Prostaglandins; 1989 Dec; 38(6):655-74. PubMed ID: 2561214
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the pharmacological profile of the potent LTB4 antagonist CP-105,696 on murine LTB4 receptors in vitro.
Showell HJ; Breslow R; Conklyn MJ; Hingorani GP; Koch K
Br J Pharmacol; 1996 Mar; 117(6):1127-32. PubMed ID: 8882606
[TBL] [Abstract][Full Text] [Related]
11. Leukotriene B4 receptor antagonist LY293111 inhibits proliferation and induces apoptosis in human pancreatic cancer cells.
Tong WG; Ding XZ; Hennig R; Witt RC; Standop J; Pour PM; Adrian TE
Clin Cancer Res; 2002 Oct; 8(10):3232-42. PubMed ID: 12374694
[TBL] [Abstract][Full Text] [Related]
12. Multiple actions of the leukotriene B4 receptor antagonist SC-41930.
Villani-Price D; Yang DC; Walsh RE; Fretland DJ; Keith RH; Kocan G; Kachur JF; Gaginella TS; Tsai BS
J Pharmacol Exp Ther; 1992 Jan; 260(1):187-91. PubMed ID: 1309871
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo pharmacological characterization of SB 201993, an eicosanoid-like LTB4 receptor antagonist with anti-inflammatory activity.
Sarau HM; Foley JJ; Schmidt DB; Martin LD; Webb EF; Tzimas MN; Breton JJ; Chabot-Fletcher M; Underwood DC; Hay DW; Kingsbury WD; Chambers PA; Pendrak I; Jakas DR; Sathe GM; Van Horn S; Daines RA; Griswold DE
Prostaglandins Leukot Essent Fatty Acids; 1999 Jul; 61(1):55-64. PubMed ID: 10477044
[TBL] [Abstract][Full Text] [Related]
14. Effect of a leukotriene B4 receptor antagonist on leukotriene B4-induced neutrophil chemotaxis in cavine dermis.
Fretland DJ; Widomski DL; Zemaitis JM; Djurić SW; Shone RL
Inflammation; 1989 Oct; 13(5):601-5. PubMed ID: 2553605
[TBL] [Abstract][Full Text] [Related]
15. The leukotriene B4 receptor agonist/antagonist activities of SC-45694 in human neutrophils.
Tsai BS; Keith RH; Villani-Price D; Haack RA; Djuric SW
J Pharmacol Exp Ther; 1994 Mar; 268(3):1493-8. PubMed ID: 8138959
[TBL] [Abstract][Full Text] [Related]
16. The in vitro and in vivo pharmacologic activity of the potent and selective leukotriene B4 receptor antagonist CP-105696.
Showell HJ; Pettipher ER; Cheng JB; Breslow R; Conklyn MJ; Farrell CA; Hingorani GP; Salter ED; Hackman BC; Wimberly DJ
J Pharmacol Exp Ther; 1995 Apr; 273(1):176-84. PubMed ID: 7714764
[TBL] [Abstract][Full Text] [Related]
17. Effects of leukotriene B4 receptor antagonist, LY293111Na, on antigen-induced bronchial hyperresponsiveness and leukocyte infiltration in sensitized guinea pigs.
Asanuma F; Kuwabara K; Arimura A; Furue Y; Fleisch JH; Hori Y
Inflamm Res; 2001 Mar; 50(3):136-41. PubMed ID: 11339501
[TBL] [Abstract][Full Text] [Related]
18. Leukotriene B4 receptor inhibitor LY293111 induces cell cycle arrest and apoptosis in human anaplastic large-cell lymphoma cells via JNK phosphorylation.
Zhang W; McQueen T; Schober W; Rassidakis G; Andreeff M; Konopleva M
Leukemia; 2005 Nov; 19(11):1977-84. PubMed ID: 16151469
[TBL] [Abstract][Full Text] [Related]
19. The preclinical pharmacological profile of the potent and selective leukotriene B4 antagonist CP-195543.
Showell HJ; Conklyn MJ; Alpert R; Hingorani GP; Wright KF; Smith MA; Stam E; Salter ED; Scampoli DN; Meltzer S; Reiter LA; Koch K; Piscopio AD; Cortina SR; Lopez-Anaya A; Pettipher ER; Milici AJ; Griffiths RJ
J Pharmacol Exp Ther; 1998 Jun; 285(3):946-54. PubMed ID: 9618393
[TBL] [Abstract][Full Text] [Related]
20. SC-41930, a leukotriene B4 receptor antagonist, inhibits 12(S)-hydroxyeicosatetraenoic acid (12(S)-HETE) binding to epidermal cells.
Kemény L; Ruzicka T
Agents Actions; 1991 Mar; 32(3-4):339-42. PubMed ID: 1650525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]